Service is in preparation Official β release coming soon. Some features are still being adjusted.

Investical Earnings & investing calendar Earnings & investing calendar
/
WWaqoo Inc. logo
4937TSE Growth

Waqoo Inc.

Waqoo Yahoo Finance

Recent & upcoming events

Aug 7
Earnings 2:00
Q3 earnings announcement (scheduled)
Add to Google Calendar
May 14
Earnings 2:00
Q2 earnings announcement (scheduled)
Add to Google Calendar
Feb 12
Earnings 1:00
Q1 earnings announcement (scheduled)
Add to Google Calendar
2025
Dec 22
Shareholder meeting Time TBD
Shareholders' meeting
Add to Google Calendar
Nov 13
Earnings 1:00
FY earnings announcement (scheduled)
Add to Google Calendar
Nov 12
Est.
Earnings 1:00 approx.
Full-year earnings
Add to Google Calendar
2027
Feb 4
Est.
Earnings 1:00 approx.
Q1 earnings
Add to Google Calendar
May 6
Est.
Earnings 2:00 approx.
Q2 earnings
Add to Google Calendar
Aug 5
Est.
Earnings 2:00 approx.
Q3 earnings
Add to Google Calendar

KPI highlights

FY25
Revenue ¥1.96B YoY +0.9%
Operating income ¥151M margin 7.7%
Net income ¥44M YoY
EPS ¥12 YoY
P/E
ROE 2.1% Equity ratio 65% Typical equity ratios vary a lot by industry. Banks, brokerages, and other financial companies tend to run lower ratios because leverage (using other people's capital) is core to their business model — a low ratio there isn't a sign of financial weakness.

Company guidance

FY2026/09 Company-issued full-year guidance (from earnings report) / %=vs prior FY
Revenue ¥2.75B +40.2%
Operating income ¥560M +271.0%
Net income ¥410M +829.9%
EPS ¥116 +838.1%

Quarterly fundamentals

Income & cash flow
Quarter FY23 Q1FY23 Q2FY23 Q3FY23 Q4FY24 Q1FY25 Q4
Revenue ¥410M¥422M¥404M¥446M¥488M
Operating income ¥129M¥49M¥20M¥-113M¥26M
Net income ¥143M¥-149M¥-34M¥-110M¥-581,000
Operating CF

Ownership over time

Share of total shares outstanding (disclosed major holdings + undisclosed)(2021–2025)

事業法人 22%国内機関 3.6%個人 45.9%未開示 28.6%20212022202320242025
事業法人国内機関海外機関個人未開示・浮動株

「国内機関」は信託銀行の名義口座(年金・パッシブ・一部海外資本を含む)を集計し、実質保有者へは分解していません。分類は開示名称からの推定です。

Top shareholders — rank & share

相川 佳之 28.1%相川 佳之井上 裕基 11%井上 裕基SBCメディカルグループ株式会社 10%SBCメディカルグループ株式会社株式会社M&M 6.8%株式会社M&M株式会社MC 5.1%株式会社MC福留 大士 3.2%福留 大士前田 敏彦 2.1%前田 敏彦株式会社日本カストディ銀行(信託口) 2%株式会社日本カストディ銀行(信託口)20212022202320242025

Top shareholders — actual figures (as of 2025)

Holder Shares held Ratio Source
相川 佳之 989,802 28.1% Yuho (EDINET)
井上 裕基 386,502 11.0% Yuho (EDINET)
SBCメディカルグループ株式会社 353,600 10.0% Yuho (EDINET)
株式会社M&M 240,456 6.8% Yuho (EDINET)
株式会社MC 180,500 5.1% Yuho (EDINET)
福留 大士 111,200 3.2% Yuho (EDINET)
前田 敏彦 74,000 2.1% Yuho (EDINET)
株式会社日本カストディ銀行(信託口) 69,800 2.0% Yuho (EDINET)
日本マスタートラスト信託銀行株式会社(信託口) 56,300 1.6% Yuho (EDINET)
佐俣 文平 54,400 1.5% Yuho (EDINET)

Source:EDINET(大株主の状況) Classification inferred from disclosed names

F-Score (Piotroski)

4/9

Checks financial health against 9 criteria and shows how many are met as a fraction (more ✓ marks is healthier). Items with no data are shown as “—” — they're simply excluded from judgment, not counted against the score.

Positive ROA ROA 1.4%
Positive operating cash flow ¥136M
ROA improved YoY -0.6% → 1.4%
Operating CF exceeds net income (accrual quality) OCF ¥136M / net income ¥44M
Equity ratio improved* Substitute for the original “decrease in long-term debt” 68.2% → 65.1%
Current ratio improved 3.10× → 2.58×
No dilution (shares outstanding did not increase) 3,618,928 → 3,622,668
Gross margin improved 79.7% → 79.5%
Asset turnover improved 0.62× → 0.61×

This score is reference information based on our own financial metrics. It is NOT a credit rating issued by a credit rating agency under Article 66-27 of the Financial Instruments and Exchange Act, and is NOT investment advice or a recommendation. Make investment decisions at your own responsibility.

Fact checklist

FY25
Equity ratio 65.1%
Current ratio 2.6×
Years of positive operating CF 6 of last 6 yrs
Payout ratio
Latest fiscal year result Profit (net income ¥44M)

Performance history

Last 10 years
0億円12億円23億円35億円47億円 FY20FY21FY22FY23FY24FY25

Income & assets

Unit: ¥100M
Item FY20FY21FY22FY23FY24FY25
Revenue 45.046.827.317.319.419.6
Operating income 1.071.49-0.402.780.561.51
Ordinary income 1.41-0.222.880.571.52
Net income 0.991.16-0.570.28-0.170.44
Total assets 11.819.015.615.831.332.0
Equity 1.618.017.437.7321.420.9

A “—” means data wasn't available for that period — it's not a display error or an unusual value.

Indicators & cash flow

Unit: ¥100M
Item FY20FY21FY22FY23FY24FY25
EPS ¥36¥41¥-19¥9¥-5¥12
ROE 61.1%3.7%2.1%
Operating CF 0.270.611.694.560.491.36
Investing CF 0.030.03-1.76-0.49-0.76-1.89
Financing CF -0.167.11-1.29-0.081.12-1.50
FCF 0.87-1.38-0.074.07-0.27-0.53

A “—” means data wasn't available for that period — it's not a display error or an unusual value.

Source: EDINET (Annual Securities Report) (fetched 2026-08-29) *Some metrics supplemented from additional sources

Sector positioning

Relative standing within the sector

Data provided by Twelve Data